Statistics

Breathalyzer Market Booms with Technological Advances; Key to Reducing Alcohol-Related Road Deaths

Retrieved on: 
星期四, 四月 25, 2024

Probation Officer, Neil Friedel stated, “In a relatively short period of time the Breath Logix device has become an invaluable device under our 24/7 Sobriety Program. The device allows our clients to autonomously get tested for breath alcohol without the need for our clinic to station a full-time administrator -- its a game changer for us. Our clinic is saving time and money daily with the Breath Logix device deployed in our office. It has quickly become part of our daily routine and work flow process in our clinic.”

Key Points: 
  • With increasing concerns over road safety and stringent legal measures against drunk driving, the demand for breathalyzers has surged globally.
  • Alcohol-impaired driving remains a critical concern worldwide, contributing significantly to road accidents and fatalities.
  • According to the World Health Organization, road traffic injuries caused by alcohol impairment are a major public health problem that account for nearly 1.35 million deaths annually.
  • In the United States alone, about 28% of all traffic-related deaths are attributed to alcohol-impaired driving.

New York housing inventory continues to set records, falls yet again in March

Retrieved on: 
星期四, 四月 18, 2024

ALBANY, N.Y., April 18, 2024 (GLOBE NEWSWIRE) -- Once again, housing inventory across New York State fell to another record low in March, according to the housing report released today by the New York State Association of REALTORS®.

Key Points: 
  • ALBANY, N.Y., April 18, 2024 (GLOBE NEWSWIRE) -- Once again, housing inventory across New York State fell to another record low in March, according to the housing report released today by the New York State Association of REALTORS®.
  • This marks the 13th consecutive month inventory has dropped in year-over-year comparisons and is the lowest number of homes for sale since statistics have been kept in New York State.
  • The New York State Association of REALTORS® is a not-for-profit trade organization representing more than 63,000 of New York State’s real estate professionals.
  • These REALTORS® are also members of the New York State Association of REALTORS® as well as their local board or association of REALTORS®.

Immutep Receives Positive Feedback from the Spanish Medicines Agency for Upcoming TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer

Retrieved on: 
星期三, 四月 17, 2024

SYDNEY, AUSTRALIA, April 17, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces it has received positive feedback from the Spanish Agency for Medicines and Health Products (AEMPS) Competent Authority regarding the Company’s upcoming TACTI-004 Phase III trial of eftilagimod alpha (“efti”) for first line treatment of metastatic non-small cell lung cancer (1L NSCLC).

Key Points: 
  • SYDNEY, AUSTRALIA, April 17, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces it has received positive feedback from the Spanish Agency for Medicines and Health Products (AEMPS) Competent Authority regarding the Company’s upcoming TACTI-004 Phase III trial of eftilagimod alpha (“efti”) for first line treatment of metastatic non-small cell lung cancer (1L NSCLC).
  • Immutep SVP, Regulatory & Strategy, Christian Mueller commented: “We continue to be pleased with our discussions with regulatory bodies around the world regarding our upcoming pivotal TACTI-004 trial and are thankful for the positive feedback and constructive guidance received by AEMPS.
  • Among the other items discussed at the meeting were general aspects of the trial design, including selection of the control arm and statistics, and the specificities of the patient population.
  • Additional interactions with regulatory agencies as well as with other stakeholders and potential partners are ongoing in a productive manner.

Nacuity Pharmaceuticals Expands Board of Directors with Appointment of Dr. Emmett Cunningham, Jr.

Retrieved on: 
星期二, 四月 16, 2024

“We’re thrilled to welcome Dr. Cunningham to our board of directors,” said Halden Conner, Chairman, CEO and Co-Founder of Nacuity Pharmaceuticals.

Key Points: 
  • “We’re thrilled to welcome Dr. Cunningham to our board of directors,” said Halden Conner, Chairman, CEO and Co-Founder of Nacuity Pharmaceuticals.
  • He is also an internationally recognized specialist in infectious and inflammatory eye disease with over 400 publications.
  • “Nacuity’s approach to treating ophthalmic and non-ophthalmic disorders is both completely novel and tremendously promising,” said Dr. Cunningham.
  • Dr. Cunningham is a member of the board of directors of Galera Therapeutics and Executive Chairman of Eyconis.

Pacific Prime’s Global Employee Benefits Trends Report 2024 Reveals Desired Benefits Beyond Salary

Retrieved on: 
星期二, 四月 30, 2024

Global health insurance brokerage and employee benefits specialist Pacific Prime has released their 2024 Global Employee Benefits Trends Report.

Key Points: 
  • Global health insurance brokerage and employee benefits specialist Pacific Prime has released their 2024 Global Employee Benefits Trends Report.
  • Catered to both HR professionals and corporations, the report offers insight into the current employee benefits landscape and tips on implementing the latest employee benefits trends to give employees a sense of belonging and improved job satisfaction.
  • As such, the introduction of these new employee benefits trends will contribute to employee attraction and retention for employers.
  • If you would like to learn more about the global employee benefits trends in 2024, scan the attached QR code or visit our website to download your free copy of the report .

Jersey Telecom (JT Group) Expands into North America with Advanced Fraud Prevention Platform and Solutions

Retrieved on: 
星期一, 四月 29, 2024

As real-time payments redefine the global financial landscape Jersey Telecom (JT Group) is intensifying its American operations to respond to the growing market.

Key Points: 
  • As real-time payments redefine the global financial landscape Jersey Telecom (JT Group) is intensifying its American operations to respond to the growing market.
  • As an advanced mobile alert system, MoneyGuard is designed to help financial institutions fight fraud through real-time omni-channel communications including SMS, WhatsApp, push alerts, email and voice.
  • This trend is forecasted to continue, driven by evolving fraud threats and the increasing adoption of real time payments.
  • MoneyGuard tackles this challenge head-on by integrating sophisticated mobile intelligence and customer engagement capabilities into everyday financial transactions, enhancing fraud detection and prevention in real-time.

Immuron Travelan® sales continued strong growth

Retrieved on: 
星期三, 四月 10, 2024

MELBOURNE, Australia, April 10, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce record sales (unaudited) of Travelan®, an over-the-counter immune supplement that targets pathogenic bacteria and the toxins they produce in the gastrointestinal (GI) tract.

Key Points: 
  • Sales of Travelan® increased 250% to AUD $2.7 million FYTD Mar 2024 compared to AUD $0.8 million FYTD Mar 2023.
  • Sales of Travelan® increased 70% to AUD $0.9 million Mar 2024 Quarter compared to AUD $0.5 million Mar 2023 Quarter.
  • Sales of Travelan® increased 7% to AUD $0.3 million Mar 2024 Quarter compared to AUD $0.3 million Mar 2023 Quarter.
  • Immuron’s investment to drive awareness of the Travelan® brand has seen continued strong sales results in Australia.

Global Non-meat Ingredients Industry Research 2024-2029: Technological Advancements to Develop New Product Lines, Growth of Indian Processed Market, & Rising Demand from Fast-Food Chains - ResearchAndMarkets.com

Retrieved on: 
星期五, 四月 26, 2024

As consumers become more adventurous in their food choices, the demand for non-meat ingredients has increased rapidly.

Key Points: 
  • As consumers become more adventurous in their food choices, the demand for non-meat ingredients has increased rapidly.
  • These ingredients play a crucial role in enhancing the flavor, texture, and overall quality of processed meat products.
  • Plant-derived ingredients may have limited availability, seasonality, and variability in quality, while animal-derived ingredients may pose ethical and cultural concerns.
  • The prevalence of large fast-food chains further drives the demand for processed meat products in the US market.

Pet Care Global Strategic Business Report 2024: Driven by Rising Prevalence of Zoonotic and Foodborne Diseases, Spending on Pet Care Rises - ResearchAndMarkets.com

Retrieved on: 
星期三, 四月 24, 2024

The "Pet Care - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pet Care - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
  • Pet Food, one of the segments analyzed in the report, is projected to record 4.9% CAGR and reach US$134.7 Billion by the end of the analysis period.
  • Growth in the Veterinary Care segment is estimated at 5.1% CAGR for the next 8-year period.
  • Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.

Advanced BI Tools Aim to Democratize Data Science in Brazil

Retrieved on: 
星期二, 四月 23, 2024

The latest ISG Provider Lens™ Analytics Platforms report for Brazil finds “citizen data scientists” are the principal target audience for BI and data governance platforms.

Key Points: 
  • The latest ISG Provider Lens™ Analytics Platforms report for Brazil finds “citizen data scientists” are the principal target audience for BI and data governance platforms.
  • “Platforms are key to democratizing the entire data journey,” said Loren Absher, ISG director, Enterprise AI Advisory.
  • “Providers in the Brazilian market are offering functionalities such as integration, data catalogs, data quality, data anonymization, and masking and access control.”
    Data governance platforms are gaining traction in Brazil as companies go beyond data integration and engineering fundamentals to ensure data reliability and availability, the ISG report says.
  • Without sufficient data governance, data model building will be unproductive, the report says.